Merck KGaA (MRK) News Today €124.60 +2.70 (+2.21%) As of 05/2/2025 Add Compare Share Share Headlines Stock AnalysisChartHeadlinesBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Is Merck & Co. Inc. (MRK) the Best Dow Stock for the Next 12 Months?April 30, 2025 | msn.comDrug-maker Merck is building a billion-dollar factory and lab center in DelawareApril 29, 2025 | msn.comMerck KGaA’s $3.9 Billion Springworks Deal to Boost US PresenceApril 28, 2025 | msn.comMerck KGaA to buy Springworks for $3.9 billionApril 28, 2025 | msn.comMerck KGaA (ETR:MRK) Stock Price Down 0.7% - Here's What HappenedMerck KGaA (ETR:MRK) Trading Down 0.7% - Here's What HappenedApril 28, 2025 | marketbeat.comGermany's Merck nears deal for SpringWorks, source saysApril 26, 2025 | msn.comMerck KGaA (ETR:MRK) Shares Down 0.7% - What's Next?April 26, 2025 | americanbankingnews.comMerck gains after latest survival data for Summit’s cancer drugApril 26, 2025 | msn.comGermany's Merck says in late-stage discussions to buy SpringWorks for $3.5 billionApril 25, 2025 | msn.comMerck Faces Lawsuit to Block Launch of Easier-to-Use KeytrudaApril 24, 2025 | bloomberg.comMerck (NYSE:MRK) Faces Patent Lawsuit As Earnings Grow US$317 Million In Q1April 24, 2025 | finance.yahoo.comMerck trims full-year profit outlook, beats Q1 estimates; shares slightly upApril 24, 2025 | investing.comMerck Expects $200 Million Tariff Hit as Gardasil Sales PlungeApril 24, 2025 | msn.comMerck’s (NYSE:MRK) Q1 Sales Beat EstimatesApril 24, 2025 | finance.yahoo.comMerck trims 2025 earnings outlook amid tariff impactApril 24, 2025 | msn.comMerck Reports Strong Q1 Earnings But Downgrades Full-Year Guidance: Retail Sentiment BrightensApril 24, 2025 | msn.comMerck's Keytruda Combination Therapy Gets Health Canada's Approval For Treatment Of Metastatic MPMApril 24, 2025 | nasdaq.comWill Q1 Earnings Send MRK Stock Lower?April 23, 2025 | forbes.comMerck initiated with a Neutral at Cantor FitzgeraldApril 23, 2025 | markets.businessinsider.comStreak Analysis Alert: Why Merck (MRK) Should Be on Your Radar This WeekApril 19, 2025 | msn.comMerck & Company (MRK) Receives a Buy from GuggenheimApril 17, 2025 | markets.businessinsider.comMerck (NYSE:MRK) Secures Global Rights To Cyprumed's Oral Peptide Delivery TechnologyApril 17, 2025 | finance.yahoo.comMorgan Stanley Sticks to Its Hold Rating for Merck & Company (MRK)April 9, 2025 | markets.businessinsider.comMerck assumed with a Buy at Goldman SachsApril 8, 2025 | markets.businessinsider.comMerck & Company (MRK) Gets a Buy from Bank of America SecuritiesApril 8, 2025 | markets.businessinsider.comMerck KGaA (ETR:MRK) Shares Down 3.1% - Here's WhyMerck KGaA (ETR:MRK) Trading Down 3.1% - Here's What HappenedApril 7, 2025 | marketbeat.comMerck (MRK) Stock Moves -0.24%: What You Should KnowApril 3, 2025 | msn.comBernstein Reaffirms Their Hold Rating on Merck & Company (MRK)April 3, 2025 | markets.businessinsider.comMerck & Company (MRK) Gets a Buy from CitiMarch 31, 2025 | markets.businessinsider.comMRK Investors Have Opportunity to Lead the Merck Securities Fraud Lawsuit with Faruqi & Faruqi, LLPMarch 29, 2025 | markets.businessinsider.comWhy Merck & Co. Inc. (MRK) Went Up On Friday?March 29, 2025 | msn.comMerck announces EC approved Capvaxive pneumococcal vaccineMarch 28, 2025 | markets.businessinsider.comMerck says 3475A-D77 Phase 3 trial met primary endpointsMarch 27, 2025 | markets.businessinsider.comMerck licenses HRS-5346 in cardiovascular disease from Hengrui PharmaMarch 26, 2025 | markets.businessinsider.comMerck KGaA (ETR:MRK) Shares Up 0.1% - Here's WhyMerck KGaA (ETR:MRK) Shares Up 0.1% - Time to Buy?March 16, 2025 | marketbeat.comThere May Be Some Bright Spots In Merck KGaA's (ETR:MRK) EarningsMarch 14, 2025 | finance.yahoo.comMerck says DOR/ISL met primary efficacy success criterion in two Phase 3 trialsMarch 13, 2025 | markets.businessinsider.comMerck scores victory in Gardasil lawsuits as judge questions evidenceMarch 13, 2025 | msn.comMerck releases positive phase 3 data on daily oral HIV drugMarch 13, 2025 | msn.comMerck prevails in US safety litigation over Gardasil HPV vaccineMarch 12, 2025 | msn.comMerck & Company (MRK) Gets a Buy from Berenberg BankMarch 12, 2025 | markets.businessinsider.comMerck wins Gardasil litigation over cancer vaccine risksMarch 11, 2025 | au.investing.comMerck opens manufacturing facility in North Carolina amid Trump's tariff threatsMarch 11, 2025 | msn.comFederal Judge Rules in Merck’s Favor in Gardasil Safety SuitMarch 11, 2025 | msn.comJudge rules in Merck’s favor over Gardasil complaints, Bloomberg saysMarch 11, 2025 | markets.businessinsider.comMerck KGaA (ETR:MRK) Has Announced A Dividend Of €2.20March 9, 2025 | finance.yahoo.comMerck KGaA Full Year 2024 Earnings: EPS Misses ExpectationsMarch 7, 2025 | finance.yahoo.comMerck KGaA (ETR:MRK) shareholders have earned a 8.1% CAGR over the last five yearsMarch 6, 2025 | finance.yahoo.comMerck’s Keytruda subject of brewing patent dispute with Halozyme, WSJ saysMarch 6, 2025 | markets.businessinsider.comMerck KGaA 2024 Sales EUR21.16BMarch 6, 2025 | marketwatch.com Get Merck KGaA News Delivered to You Automatically Sign up to receive the latest news and ratings for MRK and its competitors with MarketBeat's FREE daily newsletter. Email Address MRK Media Mentions By Week MRK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MRK News Sentiment▼0.370.58▲Average Medical News Sentiment MRK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MRK Articles This Week▼54▲MRK Articles Average Week Get Merck KGaA News Delivered to You Automatically Sign up to receive the latest news and ratings for MRK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MorphoSys News Today ad pepper media International News Today Genfit News Today Evotec News Today Siemens Healthineers News Today Bayer Aktiengesellschaft News Today Sartorius Aktiengesellschaft News Today Fresenius Medical Care News Today Carl Zeiss Meditec News Today Gerresheimer News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ETR:MRK) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Merck KGaA Please log in to your account or sign up in order to add this asset to your watchlist. Share Merck KGaA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MRK Stock Free MRK Stock Alerts